Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cabozantinib Demonstrates Encouraging Activity in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma
Yahoo/Business Wire
Sunday, June 3, 2012 - 11:09am
tags:
cabozantinib, renal cell carcinoma, Exelixis
The Market Is Wrong About Vertex
Motley Fool
Sunday, June 3, 2012 - 11:08am
tags:
Vertex Pharmaceuticals
Puma Biotechnology presents positive PB272 clinical data at ASCO
Yahoo/The Fly On The Wall
Sunday, June 3, 2012 - 11:07am
tags:
Puma Biotechnology, PB272, breast cancer
Oncothyreon Announces Presentation of PX-866 Clinical Data at American Association of Clinical Oncology Annual Meeting
Yahoo/PR NewsWire
Sunday, June 3, 2012 - 11:06am
tags:
PX-866, Oncothyreon, non-small cell lung cancer, squamous cell cancer
Reliv Announces Breakthrough in Fight Against Metabolic Syndrome
Yahoo/PR NewsWire
Sunday, June 3, 2012 - 11:02am
tags:
Reliv, metabolic syndrome, GlucAffect, LunaRich
Bristol CEO says Gilead holding out on hep C tie-up
Fierce Biotech
Friday, June 1, 2012 - 12:30pm
tags:
Bristol-Myers Squibb, Gilead, hepatitis C, Lamberto Andreotti, daclatasvir, GS-7977
ASCO spotlight: Antibody-drug conjugates arrive
Fierce Biotech
Friday, June 1, 2012 - 12:28pm
tags:
ASCO, antibody-drug conjugate, Roche, Genentech, Immunogen, T-DM1, Adcetris, Seattle Genetics
CVS takes aim at co-pay cards by blocking drug coverage
Fierce Pharma
Friday, June 1, 2012 - 12:25pm
tags:
CVS, co-pay cards
CHMP in Favor of Lilly's Jentadueto
Yahoo/Zacks
Friday, June 1, 2012 - 12:24pm
tags:
Eli Lilly, Jentadueto, CHMP, diabetes
Clearing Up Vertex's Data Bungle
Forbes
Friday, June 1, 2012 - 12:18pm
tags:
Vertex Pharmaceuticals, cystic fibrosis, Kalydeco, VX-809
Baxter And Neostem Validating Each Other's Cell Therapies
Seeking Alpha
Friday, June 1, 2012 - 12:15pm
tags:
Baxter, NeoStem, stem cells, Dendreon, Osiris
PharmAthene rises as judge upholds ruling awarding it half the profits on Siga smallpox drug
Yahoo/AP
Friday, June 1, 2012 - 12:14pm
tags:
SIGA technologies, smallpox, PharmAthene, ST-246
Bristol-Myers Might Be Ahead Of Competition In Race To Cure Cancer
Seeking Alpha
Friday, June 1, 2012 - 12:12pm
tags:
Bristol-Myers Squibb, cancer, GSK, Merck, Teva Pharmaceuticals
Merck has no plans to sell animal and consumer health businesses
NJ.com
Friday, June 1, 2012 - 10:32am
tags:
Merck, animal health, M&A, OTC
Study details cancer risk of Takeda diabetes pill
Reuters
Friday, June 1, 2012 - 10:30am
tags:
diabetes, bladder cancer, Takeda, Actos
J&J files diabetes drug canagliflozin with FDA
Pharma Times, UK
Friday, June 1, 2012 - 10:29am
tags:
diabetes, JNJ, FDA, canagliflozin
Forest Laboratories and Nabriva Therapeutics Sign Agreement
Yahoo
Friday, June 1, 2012 - 10:28am
tags:
Forest Labs, Nabriva Therapeutics, BC-3781, M&A
Trius: Tedizolid Prospects In MRSA Lead To Initiation With A Buy
Seeking Alpha
Friday, June 1, 2012 - 10:27am
tags:
Trius Therapeutics, MRSA, tedizolid, antibiotics
Cancer Incidence May Surge 75% By 2030, Lancet Says
Bloomberg
Friday, June 1, 2012 - 10:26am
tags:
cancer
WebMD snares former Pfizer exec as CEO
Yahoo/AP
Friday, June 1, 2012 - 10:25am
tags:
Pfizer, WebMD

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.